E Carmack Holmes - Net Worth and Insider Trading
E Carmack Holmes Net Worth
The estimated net worth of E Carmack Holmes is at least $5 dollars as of 2024-11-13. E Carmack Holmes is the Director of Plus Therapeutics Inc and owns about 4 shares of Plus Therapeutics Inc (PSTV) stock worth over $5. Details can be seen in E Carmack Holmes's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that E Carmack Holmes has not made any transactions after 2011-08-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of E Carmack Holmes
E Carmack Holmes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, E Carmack Holmes owns 1 companies in total, including Plus Therapeutics Inc (PSTV) .
Click here to see the complete history of E Carmack Holmes’s form 4 insider trades.
Insider Ownership Summary of E Carmack Holmes
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PSTV | Plus Therapeutics Inc | 2011-08-19 | director |
E Carmack Holmes Latest Holdings Summary
E Carmack Holmes currently owns a total of 1 stock. E Carmack Holmes owns 4 shares of Plus Therapeutics Inc (PSTV) as of August 19, 2011, with a value of $5.
Latest Holdings of E Carmack Holmes
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PSTV | Plus Therapeutics Inc | 2011-08-19 | 4 | 1.29 | 5 |
Holding Weightings of E Carmack Holmes
E Carmack Holmes Form 4 Trading Tracker
According to the SEC Form 4 filings, E Carmack Holmes has made a total of 0 transactions in Plus Therapeutics Inc (PSTV) over the past 5 years. The most-recent trade in Plus Therapeutics Inc is the acquisition of 0 shares on August 19, 2011, which cost E Carmack Holmes around $9,450.
Insider Trading History of E Carmack Holmes
- 1
E Carmack Holmes Trading Performance
GuruFocus tracks the stock performance after each of E Carmack Holmes's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by E Carmack Holmes is -7.57%. GuruFocus also compares E Carmack Holmes's trading performance to market benchmark return within the same time period. The performance of stocks bought by E Carmack Holmes within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how E Carmack Holmes's insider trading performs compared to the benchmark.
Performance of E Carmack Holmes
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.94 | | | | | |
| Relative Return to S&P 500(%) | -0.23 | | | | | |
E Carmack Holmes Ownership Network
Ownership Network List of E Carmack Holmes
Ownership Network Relation of E Carmack Holmes
E Carmack Holmes Owned Company Details
What does Plus Therapeutics Inc do?
Who are the key executives at Plus Therapeutics Inc?
E Carmack Holmes is the director of Plus Therapeutics Inc. Other key executives at Plus Therapeutics Inc include President Marc H Hedrick , Chief Financial Officer Sims Andrew John Hugh Macintyre , and CHIEF MEDICAL OFFICER Norman D. Lafrance .
Plus Therapeutics Inc (PSTV) Insider Trades Summary
Over the past 18 months, E Carmack Holmes made no insider transaction in Plus Therapeutics Inc (PSTV). Other recent insider transactions involving Plus Therapeutics Inc (PSTV) include a net purchase of 28,761 shares made by Robert P Lenk , a net purchase of 22,797 shares made by Howard Clowes , and a net purchase of 44,755 shares made by Greg Petersen .
In summary, during the past 3 months, insiders sold 0 shares of Plus Therapeutics Inc (PSTV) in total and bought 39,883 shares, with a net purchase of 39,883 shares. During the past 18 months, 2,068 shares of Plus Therapeutics Inc (PSTV) were sold and 140,755 shares were bought by its insiders, resulting in a net purchase of 138,687 shares.
Plus Therapeutics Inc (PSTV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Plus Therapeutics Inc Insider Transactions
E Carmack Holmes Mailing Address
Above is the net worth, insider trading, and ownership report for E Carmack Holmes. You might contact E Carmack Holmes via mailing address: Ucla Dept Of Surgery, 10835 Lecente Ave, Los Angeles Ca 90095.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
